Sumitomo Dainippon Pharma Annual Report 2017
83/102

Proceeds from sales of available-for-sale securities were ¥8,935 million ($79,777 thousand) and ¥6,383 million for the years ended March 31, 2017 and 2016, respectively. Realized gains from sales of available-for-sale securities were ¥5,754 million ($51,375 thousand) and ¥6,107 million for the years ended March 31, 2017 and 2016, and costs on sales of available-for-sale securities were ¥3,181 million ($28,402 thousand) and ¥277 million for the years ended March 31, 2017 and 2016, respectively. The cost of securities sold when computing realized gains was determined using the moving average method. On March 31, 2017, investment securities of ¥68 million ($607 thousand) were pledged as collateral for accounts payable of ¥70 million ($625 thousand). On March 31, 2016, investment securities of ¥52 million were pledged as collateral for accounts payable of ¥77 million.The Group is exposed to certain market risk arising from its foreign exchange forward contracts. The Group is also exposed to the risk of credit loss in the event of non-performance by the counterparties to its currency contracts. However, the Group does not anticipate non-performance by any of these counterparties as they are nancial institutions with high credit ratings.7. DERIVATIVE TRANSACTIONSDerivative transactions as of March 31, 2017 were as follows:1) Currency related derivative transactions for which hedge accounting is not applied Not applicable2) Currency related derivative transactions to which hedge accounting is applied Main items hedged by foreign forward exchange forward contracts are trade accounts payable.Contract amountsPortion over1 yearMillions of yenThousands of U.S. dollarsTransaction typeTotalFair valuePortion over1 yearTotalFair value¥ 1,900473221¥ 2,594$ 16,9654,2231,973$ 23,161¥ (28)(2)(1)¥ (31)$ (250) (18)(9)$ (277)————————USDEURTHBTotalContract amountsBuy contracts Foreign exchangeforward contractsContract amountsPortion over1 yearMillions of yenThousands of U.S. dollarsTransaction typeTotalFair valuePortion over1 yearTotalFair value¥ 43052—23¥ 505$ 3,839464—206$ 4,509————————————————————USDEURGBPTHBTotalContract amountsBuy contracts Foreign exchangeforward contractsThe following foreign exchange forward contracts meet certain conditions and their corresponding hedged items are stated at the forward exchange contract rates. Main items hedged by foreign exchange forward contracts are trade accounts payable, and their fair values are included in those of their hedged items in the notes of “5.Financial instruments”.82Sumitomo Dainippon Pharma Co., Ltd. Annual Report 2017

元のページ  ../index.html#83

このブックを見る